FERREX 150  FORTE - iron, folic acid and cyanocobalamin capsule 
Breckenridge Pharmaceutical, Inc.

----------

Ferrex™ 150
Forte
Capsules

DESCRIPTION

Ferrex™ 150 Forte Capsules are a highly water soluble complex of iron/low molecular weight polysaccharide and vitamins.

Each Ferrex™ 150 Forte Capsule contains:

Elemental Iron (as Polysaccharide Iron)	150 mg
Folic Acid	1 mg
Vitamin B12 (Cyanocobalamin)	25 mcg

Inactive Ingredients: Citric Acid, Croscarmellose Sodium, Dicalcium Phosphate, FD&C Blue No.1 Lake, FD&C Red No. 40 Lake, Gelatin, Microcrystalline Cellulose, Polyethylene Glycol, Polyvinylpyrrolidone, Sodium Lauryl Sulfate, Stearic Acid and Titanium Dioxide.

DOSAGE AND ADMINISTRATION

Usual adult dosage is 1 capsule daily, or as directed by a physician.

INDICATIONS AND USAGE

Ferrex™ 150 Forte is indicated for the dietary management of iron deficiency anemia and/or nutritional megaloblastic anemias.

CONTRAINDICATIONS

Ferrex™ 150 Forte is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron supplementation.

WARNING

Folic Acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

PRECAUTIONS

General

Do not exceed recommended dose.

The type of anemia and the underlying cause or causes should be determined before starting Ferrex™ 150 Forte. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.

Folic Acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia.

Pediatric Use

Safety and effectiveness in pediatric patients have not been established.

Geriatric Use

Clinical studies on this product have not been performed in subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

ADVERSE REACTIONS

Adverse reactions with iron supplementation may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

OVERDOSAGE

The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.

HOW SUPPLIED

Ferrex™ 150 Forte capsules are available as an opaque maroon capsule, imprinted B 198. Supplied in Unit Dose blister packs, 10 capsules per card, NDC 51991-198-11.

Warning: Keep this and all medications out of the reach of children.

If pregnant, or planning to become pregnant or are currently breast-feeding please contact your physician, or health-care provider before using or continuing use.

Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F). See USP Controlled Room Temperature.

Protect from light and moisture.

All prescription substitutions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.

Rx Only

Manufactured by:
Contract Pharmacal Corp.
Hauppauge, NY 11788 USA
www.cpc.com
Rev. 08/09

Distributed by:
Breckenridge Pharmaceutical, Inc.
Boca Raton, FL 33487

PRINCIPAL DISPLAY PANEL - 100 Capsule Carton

Breckenridge
Pharmaceutical, Inc.

NDC 51991-198-11

Ferrex™ 150
Forte
Capsules

Rx Only

100 CAPSULES

(10 x 10) Unit Dose

FERREX 150   FORTE iron, folic acid, and cyanocobalamin   capsule

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 51991-198 Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength IRON (IRON) IRON 150 mg FOLIC ACID (FOLIC ACID) FOLIC ACID 1 mg CYANOCOBALAMIN (CYANOCOBALAMIN) CYANOCOBALAMIN 25 ug

Inactive Ingredients Ingredient Name Strength Citric Acid Monohydrate   Croscarmellose Sodium   Anhydrous Dibasic Calcium Phosphate   FD&C Blue No. 1   FD&C Red No. 40   Aluminum Oxide   Gelatin   Cellulose, Microcrystalline   Polyethylene Glycol   Povidone K30   Sodium Lauryl Sulfate   Stearic Acid   Titanium Dioxide

Product Characteristics Color RED (Opaque Maroon) Score no score Shape CAPSULE Size 19mm Flavor Imprint Code B;198 Contains

Packaging # NDC Package Description Multilevel Packaging 1 51991-198-11 10 BLISTER PACK In 1 CARTON contains a BLISTER PACK 1 10 CAPSULE In 1 BLISTER PACK This package is contained within the CARTON (51991-198-11)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
UNAPPROVED DRUG OTHER		04/01/2001	05/30/2012

Labeler - Breckenridge Pharmaceutical, Inc. (150554335)

Establishment
Name	Address	ID/FEI	Operations
Contract Pharmacal Corp.		057795122	MANUFACTURE

Revised: 03/2011Breckenridge Pharmaceutical, Inc.